This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hwang, J.-S.
Right arrow Articles by Bogner, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, J.-S.
Right arrow Articles by Bogner, E.

 Previous Article  |  Next Article 

Journal of Virology, November 2007, p. 11604-11611, Vol. 81, No. 21
0022-538X/07/$08.00+0     doi:10.1128/JVI.01130-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Identification of Acetylated, Tetrahalogenated Benzimidazole D-Ribonucleosides with Enhanced Activity against Human Cytomegalovirus{triangledown}

Jae-Seon Hwang,1 Oliver Kregler,1 Rita Schilf,1 Norbert Bannert,2 John C. Drach,3,4 Leroy B. Townsend,4 and Elke Bogner1*

Institut für Virologie, Charité Universitätsmedizin Berlin, Berlin, Germany,1 Robert Koch-Institut, Berlin, Germany,2 Department of Biologic and Materials Sciences, School of Dentistry,3 Interdepartmental Graduate Program in Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan4

Received 24 May 2007/ Accepted 18 July 2007

DNA packaging is the key step in viral maturation and involves binding and cleavage of viral DNA containing specific DNA-packaging motifs. This process is mediated by a group of specific enzymes called terminases. We previously demonstrated that the human cytomegalovirus (HCMV) terminase is composed of the large subunit pUL56 and the small subunit pUL89. While the large subunit mediates sequence-specific DNA binding and ATP hydrolysis, pUL89 is required only for duplex nicking. An excellent inhibitor targeting HCMV terminase is 2-bromo-5,6-dichloro-1-(ß-D-ribofuranosyl)benzimidazole (BDCRB), but it was not developed as an antiviral drug due to its metabolic cleavage in experimental animals. We now have tested several new benzimidazole D-ribonucleosides in order to determine whether these compounds represent new, potent inhibitors. Analysis by bioluminometric ATPase activity assays identified two of the new compounds with a high inhibitory effect, 2-bromo-4,5,6-trichloro-1-(2,3,5-tri-O-acetyl-ß-D-ribofuranosyl) benzimidazole (BTCRB) and 2,4,5,6-tetrachloro-1-(2,3,5-tri-O-acetyl-ß-D-ribofuranosyl benzimidazole (Cl4RB). By using viral plaque formation, viral yield, and viral growth kinetics, we demonstrated that the two compounds BTCRB and Cl4RB had antiviral activities similar to that of BDCRB. Interestingly, BTCRB retained its inhibitory activity after preincubation with HFF cells. By use of electron microscopy, we observed an increase of B capsids and a lack of cytoplasmic capsids in the presence of the compounds that correlated with the virus yield. Furthermore, cleavage of concatenated DNA was inhibited by both compounds, and inhibition by BTCRB was shown to be dose dependent. These results demonstrate that the new compounds are highly active against HCMV and act by mechanisms similar but not identical to those of BDCRB.

* Corresponding author. Mailing address: Institut für Virologie, Charité Campus Mitte, Charitéplatz 1, 10117 Berlin, Germany. Phone: 49-30-450525121. Fax: 49-30-450525907. E-mail: elke.bogner{at}charite.de

{triangledown} Published ahead of print on 29 August 2007.

Journal of Virology, November 2007, p. 11604-11611, Vol. 81, No. 21
0022-538X/07/$08.00+0     doi:10.1128/JVI.01130-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Hwang, J.-S., Schilf, R., Drach, J. C., Townsend, L. B., Bogner, E. (2009). Susceptibilities of Human Cytomegalovirus Clinical Isolates and Other Herpesviruses to New Acetylated, Tetrahalogenated Benzimidazole D-Ribonucleosides. Antimicrob. Agents Chemother. 53: 5095-5101 [Abstract] [Full Text]  
  • Wang, J. B., McVoy, M. A. (2008). Mutagenesis of the murine cytomegalovirus M56 terminase gene. J. Gen. Virol. 89: 2864-2868 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»